CANT1 and Desbuquois dysplasia: Secondly, investigating the pathogenic pathways involving CANT1 and other relevant genes in Desbuquois dysplasia, particularly in comparison with their roles in other conditions, such as cancers, could uncover new insights into the disease’s underlying mechanisms and identify potential biomarkers for earlier diagnosis or predicting disease progression.